Pfizer and BioNTech seek emergency vaccine approval

Pfizer and BioNTech are to seek emergency government approval for their coronavirus vaccine
Pfizer and BioNTech are to seek emergency government approval for their coronavirus vaccine (AP)
23:23pm, Thu 19 Nov 2020
CBAD8A00-D2B9-4E0E-ADDF-D0366C357A34 Created with sketchtool. E9A4AA46-7DC3-48B8-9CE2-D75274FB8967 Created with sketchtool. 65CCAE04-4748-4D0F-8696-A91D8EB3E7DC Created with sketchtool.

Pharmaceutical companies Pfizer and BioNTech are to seek emergency government approval for their coronavirus vaccine, as the US aims to begin administering doses by the end of the year.

Health and Human Services Secretary Alex Azar said the companies would seek an emergency use authorisation on Friday from the Food and Drug Administration (FDA).

The application and clinical trial data will be reviewed by an independent board of scientists before approval is granted.

Mr Azar said: “Hope and help are on the way.”

This week the companies said their vaccine was 95% effective.

Moderna is expected to file for emergency approval for its own vaccine candidate in the coming weeks.

Sign up to our newsletter